Kennedy Capital Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217K | Buy |
6,671
+165
| +3% | +$5.36K | 0.01% | 565 |
|
|
2025
Q1 | $246K | Sell |
6,506
-10,020
| -61% | -$378K | 0.01% | 620 |
|
|
2024
Q4 | $1.35M | Buy |
+16,526
| New | +$1.35M | 0.03% | 563 |
|
|
2024
Q3 | – | Sell |
-6,252
| Closed | -$472K | – | 720 |
|
|
2024
Q2 | $472K | Buy |
6,252
+2,482
| +66% | +$187K | 0.01% | 640 |
|
|
2024
Q1 | $258K | Buy |
+3,770
| New | +$258K | 0.01% | 690 |
|